CONCORD BIOTECH
Back to Cashflow Statement
|
CONCORD BIOTECH Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-113 Cr | ₹-99 Cr | ₹-99 Cr | ₹-85 Cr | ₹-100 Cr |
What is the latest Cash Flow from Financing Activities ratio of CONCORD BIOTECH ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-113 Cr |
| Mar2025 | ₹-99 Cr |
| Mar2024 | ₹-99 Cr |
| Mar2023 | ₹-85 Cr |
| Mar2022 | ₹-100 Cr |
How is Cash Flow from Financing Activities of CONCORD BIOTECH Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-113 Cr | Negative | |
| Mar2025 | ₹-99 Cr | Negative | |
| Mar2024 | ₹-99 Cr | Negative | |
| Mar2023 | ₹-85 Cr | Negative | |
| Mar2022 | ₹-100 Cr | - | |
Compare Cash Flow from Financing Activities of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹14,775.3 Cr | 13% | 10.6% | -30.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,946.0 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,907.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| CIPLA | ₹118,674.0 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,648.7 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | 13% |
10.6% |
-30.9% |
| SENSEX | 2.4% |
1.5% |
-4.3% |
You may also like the below Video Courses